Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05889286 · ClinicalTrials.gov registry record
F18-MHF: Orthopedic Implants-Associated Infection Detection
A clinical trial of Knee Infection and Knee Disease, sponsored by Emory University.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05889286: Recruiting study of Knee Infection and Knee Disease, sponsored by Emory University.
NCT05889286 is a study of Knee Infection and Knee Disease that is actively recruiting participants, run by Emory University. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05889286, a study of Knee Infection and Knee Disease, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Following intravenous injection of \[F-18\]MHF as a bolus, dynamic PET imaging of the lower limbs will be acquired for approximately 90 minutes. The acquired images will be processed and viewed on a MIMVista or similar workstation. The uptake pattern of \[F-18\]MHF around infected orthopedic knee implant will be determined and compared with its uptake pattern around non-infected knee implants. This study will look at how \[18F\]MHF goes into normal knee replacements and those with suspected infection.
Primary Outcome
Number of patients who are positive on \[F-18\]MHF who also have orthopedic implant-associated infections as established by the standard of truth during surgery
Conditions Studied
Interventions
- DRUG [F-18]MHF
Study Locations (1)
Georgia
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2026-03-31 |
What NCT05889286 shows while recruiting
NCT05889286 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 2 conditions, with Knee Infection appearing as the primary indexed condition, and to 1 intervention - of which [F-18]MHF is the first listed.
NCT05889286 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05889286 about?
NCT05889286 is a clinical study titled "F18-MHF: Orthopedic Implants-Associated Infection Detection". Following intravenous injection of \[F-18\]MHF as a bolus, dynamic PET imaging of the lower limbs will be acquired for approximately 90 minutes. The acquired images will be processed and viewed on a MIMVista or similar workstation. The uptake pattern of \[F-18\]MHF around infected orthopedic knee im...
What is the current status of trial NCT05889286?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-11-04. Estimated completion is 2026-03-31.
What conditions does trial NCT05889286 study?
This clinical trial studies the following conditions: Knee Infection, Knee Disease.
What interventions are being tested in trial NCT05889286?
The interventions under investigation include: [F-18]MHF (DRUG).
Who is sponsoring clinical trial NCT05889286?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05889286 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI